$ 1.5 billion
Completed
31/5/2016
Kurt Stumpo - Journalist - North America and the Caribbean
United States
Ireland
Public acquisition
M&A
Pharmaceuticals and life sciences
Party: Jazz Pharmaceuticals (Acquirer)
Party: Celator Pharmaceuticals (Target)